Azienda Ospedaliera Santi Antonio e Biagio e Cesare Arrigo

Alessandria 15121

0 studies enrolling now · 6 studies all time

What they study most

Carcinoma, Non-Small-Cell Lung, Cardiogenic Shock, Chronic Kidney Disease, Chronic Myelomonocytic Leukemia, MDS, Mesothelioma, Myelodysplastic Syndromes, RAEB

Studies at this site

• A Safety and Efficacy Trial of Istaroxime for Cardiogenic Shock Stage C — Running, not enrolling
• EMPA-KIDNEY (The Study of Heart and Kidney Protection With Empagliflozin) — Completed
• The Safety and Efficacy of Istaroxime for Pre-Cardiogenic Shock — Completed
• Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts — Completed
• Real World Data on Gi(l)Otrif® Dose Adjustment — Completed
• Nintedanib (BIBF 1120) in Mesothelioma — Stopped early